Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.87−0.00 (-0.52%)
Close on Nov 18, 2026Market cap $6.99MP/E –Yield –
Immuron net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2026 it was -A$3.68M. The highest annual figure on record is -A$2.85M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -A$3.68M | – |
| FY2025 | Jun 30, 2025 | -A$5.22M | – |
| FY2024 | Jun 30, 2024 | -A$6.94M | – |
| FY2023 | Jun 30, 2023 | -A$3.79M | – |
| FY2022 | Jun 30, 2022 | -A$2.85M | – |
| FY2021 | Jun 30, 2021 | -A$8.38M | – |
| FY2020 | Jun 30, 2020 | -A$2.93M | – |
| FY2019 | Jun 30, 2019 | -A$4.66M | – |
See a number that looks wrong?